Contents

Search


mifepristone (Mifeprex, RU-486, Mifegyne)

Controversial abortion pill. Available 11/2000; Indications: - termination of pregnancy of < 70 day duration Dosage: 1) 3 office visits vs dispensed by mail [6] 2) 1st visit: 200 mg mifepristone tablet - formerly 600 mg (3 tablets) [4] - not necessary to observe in a medical facility 3) 2 days later, 400 ug of buccal misoprostol - unclear with new labeling that this step required [4] - vaginal misoprostol 24 hours later [5] 4) doxycline 100 mg PO BID 5) follow-up after 2 weeks to confirm termination of pregnancy Mechanism of action: 1) anti-progestin; interrupts pregnancy 2) misoprostol stimulates uterine contractions 3) combination of mifepristone followed by misoprostol is 95% effective in terminating pregnancies during the 1st 7 weeks 4) RU486 also antagonizes glucocorticoid receptors Adverse effects: - septic death (4 cases) - Clostridium sordellii etiologic agent in 2 of 4 cases [2] Mifeprex info: (877) 432-7596 or www.earlyoptionpill.com

General

endocrine agent

Database Correlations

PUBCHEM correlations

References

  1. Prescriber's Letter 7(10):56 2000
  2. FDA Medwatch http://www.fda.gov/medwatch/safety/2005/safety05.htm#Mifeprex http://www.fda.gov/medwatch/safety/2006/safety06.htm#Mifeprex
  3. FDA Drug Safety. March 30, 2016 Mifeprex (mifepristone) Information http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111323.htm
  4. Greene MF, Drazen JM A New Label for Mifepristone. N Engl J Med 2016; 374:2281-2282. June 9, 2016 PMID: 27276566 http://www.nejm.org/doi/full/10.1056/NEJMe1604462
  5. Schreiber CA, Creinin MD, Atrio J et al. Mifepristone pretreatment for the medical management of early pregnancy loss. N Engl J Med 2018 Jun 7; 378:2161. June 7, 2018 PMID: 29874535 https://www.nejm.org/doi/10.1056/NEJMoa1715726 - Westhoff CL. A better medical regimen for the management of miscarriage. N Engl J Med 2018 Jun 7; 378:2232. June 7, 2018 PMID: 29874544 https://www.nejm.org/doi/10.1056/NEJMe1804945
  6. US Food & Drug Administration. Jan 24, 2023 Information about Mifepristone for Medical Termination of Pregnancy Through Ten Weeks Gestation. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/information-about-mifepristone-medical-termination-pregnancy-through-ten-weeks-gestation